Koers Almirall SA CBOE EUROPE EQUITIES
Aandelen
ES0157097017
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- EUR | - |
13/03 | Almirall tekent licentieovereenkomst met Eloxx Pharmaceuticals voor behandeling van huidziekten | MT |
19/02 | Transcript : Almirall, S.A., 2023 Earnings Call, Feb 19, 2024 |
Omzet 2024 * | 971 mln. 1,05 mld. | Omzet 2025 * | 1,07 mld. 1,15 mld. | Marktkapitalisatie | 1,82 mld. 1,96 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 25 mln. 26,9 mln. | Nettowinst (verlies) 2025 * | 62 mln. 66,72 mln. | EV/omzet 2024 * | 1,79 x |
Nettoliquiditeiten 2024 * | 81,01 mln. 87,17 mln. | Nettoliquiditeiten 2025 * | 115 mln. 123 mln. | EV/omzet 2025 * | 1,59 x |
K/w-verhouding 2024 * |
84,4
x | K/w-verhouding 2025 * |
30,3
x | Werknemers | - |
Dividendrendement 2024 * |
2,15% | Dividendrendement 2025 * |
2,18% | Vrij verhandelbaar | 34,78% |
Recentste transcriptie over Almirall SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 25-07-14 | |
Director of Finance/CFO | 54 | 11-11-19 | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 07-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 81 | 29-05-07 | |
Seth J. Orlow
BRD | Director/Board Member | - | 01-01-16 |
Eva-Lotta Allan
BRD | Director/Board Member | 65 | 01-07-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |